GE HealthCare has raised the curtain on a new CT system with features designed specifically for addressing cardiovascular disease. The Revolution Vibe scanner includes what the company describes as ...

GE HealthCare GEHC recently unveiled new advancements in precision cardiac care at the 2025 SNMMI annual meeting in New Orleans, with a spotlight on Flyrcado—its FDA-approved Positron Emission ...

GE HealthCare’s Revolution Vibe CTi enables more facilities to elevate patient care by offering advanced cardiac imaging technology that helps deliver fast, accurate diagnoses, improve operational ...

The nation's largest network of private cardiology groups will broaden its adoption of GE HealthCare's PET scan radiotracer drug Flyrcado, helping move the Chicago-based medical equipment maker toward ...

GE HealthCare has received European approval for two cardiac imaging devices: a wireless handheld ultrasound and a device capable of running a CT scan without a patient's electrocardiogram signal. The ...

CHICAGO & BARCELONA, Spain--(BUSINESS WIRE)--At the European Association of Nuclear Medicine (EANM) Annual Meeting, GE Healthcare proudly introduces Omni Legend i, the first system on its all-new, all ...

The U.S. FDA has granted 510(k) clearance to GE Healthcare Technologies Inc. for its Precision DL for PET/CT, an artificial intelligence and deep learning (DL)-powered software designed to sharpen ...

GE HealthCare’s agreement with CardioNavix, a part of the CDL Nuclear Technologies services group, further broadens the reach of Flyrcado. Through their nearly 225 U.S. customers, CDL and CardioNavix ...

CHICAGO - GE HealthCare (GEHC), a prominent player in the Healthcare Equipment & Supplies industry with a market capitalization of $34.82 billion, announced Monday it has submitted a 510(k) ...

"Revolution Vibe has significantly enhanced our cardiac imaging capabilities, doubling our CCTA capacity while reducing scan times and improving image quality,” shares Dr. Christopher Ahlers, ...